Form 8-K - Current report:
SEC Accession No. 0001860742-25-000003
Filing Date
2025-02-19
Accepted
2025-02-19 07:01:56
Documents
15
Period of Report
2025-02-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blco-20250219.htm   iXBRL 8-K 28739
2 EX-99.1 ex991q4-2024.htm EX-99.1 483648
6 BL LOGO bllogo-hires.jpg GRAPHIC 223158
  Complete submission text file 0001860742-25-000003.txt   973525

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blco-20250219.xsd EX-101.SCH 1776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blco-20250219_lab.xml EX-101.LAB 22490
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blco-20250219_pre.xml EX-101.PRE 13030
18 EXTRACTED XBRL INSTANCE DOCUMENT blco-20250219_htm.xml XML 2791
Mailing Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4
Business Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4 908-541-5456
Bausch & Lomb Corp (Filer) CIK: 0001860742 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41380 | Film No.: 25637153
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)